A comprehensive <scp>AI</scp>‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging
Frank W. Pun(Hong Kong Science and Technology Parks Corporation), Alex Zhavoronkov(Hong Kong Science and Technology Parks Corporation), Tomas Schmauck‐Medina(University of Oslo), Hoi-Wing Leung(Chinese University of Hong Kong), Sofie Lautrup(University of Oslo), Xi Long(Hong Kong Science and Technology Parks Corporation), Geoffrey Ho Duen Leung(Hong Kong Science and Technology Parks Corporation), Evandro Fei Fang(National Institutes of Health), Nishant Agrawal(University of Chicago), Ari J. Rosenberg(University of Chicago), Ivan V. Ozerov(Hong Kong Science and Technology Parks Corporation), Chun Wai Wong(E I L (China)), Feng Ren(Unknown), Jared Rice(University of Oslo), Evgeny Izumchenko(University of Chicago), Alex Aliper(Hong Kong Science and Technology Parks Corporation), Bonnie Hei Man Liu(Hong Kong Science and Technology Parks Corporation)
Cited by 40
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>
|Science|2011|1.7k
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
|Trends in Neurosciences|2017|861